ETF Channel
Market News Video Self Directed Investor The Warren Buffetts Next Door Stock message boards Portfolio Channel


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
www.valueforum.com/7/
Free ETF Newsletter
Stock Weight Amount
Amgen 8.44% $637,938,057
Biogen 8.25% $623,571,807
Celgene 7.98% $602,928,054
Regeneron Pharmaceuticals 7.06% $533,879,690
Gilead Sciences 6.99% $527,915,910
Illumina 4.44% $335,760,632
Vertex Pharmaceuticals 4.05% $305,713,226
Mylan NV 3.87% $292,257,279
Alexion Pharmaceuticals 3.31% $250,501,998
Shire Adr Representing Plc 3.00% $226,457,416
Biomarin Pharmaceutical 2.77% $209,286,147
Incyte 2.69% $203,245,893
Medivation 2.35% $177,380,214
Jazz Pharmaceuticals Plc 1.35% $102,194,878
Alkermes Plc 1.20% $90,369,352
Seattle Genetics 1.14% $86,139,718
Qiagen N.V. 1.12% $84,267,543
Alnylam Pharmaceuticals 1.09% $82,475,161
United Therapeutics 0.97% $73,361,003
Endo International Plc 0.82% $62,004,743
Page 1 2 3 4 5 6 next »
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
25 Dividend Giants Widely Held By ETFs
25 S.A.F.E. Dividend Stocks Increasing Payments For Decades
Broker Darlings: Top 15 Analyst Picks of the Dow
Top 25 Broker Analyst Picks of the S&P 500
Forgotten S&P 500 Giants: Analysts' Current Least Favorites
25 Top Ranked Socially Responsible Dividend Stocks
10 Oversold ETFs
The Top 10 DividendRank'ed Stocks
Warren Buffett Dividend Stocks
The DividendRank Top 25
The Top 10 DividendRank'ed DJIA Components
The Top 10 DividendRank'ed Dow Transports Components
The Top 10 DividendRank'ed Dow Utilities Components
The Top 10 DividendRank'ed Nasdaq 100 Components
10 Stocks Going Ex-Dividend
10 Oversold Dividend Stocks
10 Stocks Where Yields Got More Juicy
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Top Ranked Dividend Stocks With Insider Buying
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Metals Stocks You Can Buy Cheaper Than Insiders Did
10 Oversold Metals Stocks
10 Must-Know High-Yield REITs
10 Top DividendRank'ed Financials
10 Top DividendRank'ed Metals Stocks
10 Oversold Energy Stocks
10 Top DividendRank'ed Energy Stocks
10 Top DividendRank'ed Utility Stocks
10 Stocks Crossing Below Book Value
10 Stocks Crossing Above Their 200 Day Moving Average
10 Stocks Crossing Below Their 200 Day Moving Average
10 ETFs Crossing Above Their 200 DMA
The 10 Biggest ETFs
The 10 Best ETF Performers
The 10 Worst ETF Performers
10 ETFs With Notable Inflows
10 ETFs With Notable Outflows
Top 10 Analyst Rated Consumer Stocks
Top 10 Analyst Rated Dividend Stocks
Top 10 Analyst Rated Energy Stocks
Top 10 Analyst Rated Financial Stocks
Top 10 Analyst Rated Healthcare Stocks
Top 10 Analyst Rated REIT Stocks
Top 10 Analyst Rated Technology Stocks
The Top 10 DividendRank'ed Canadian Stocks
The DividendRank Canada Top 25
10 Canadian Stocks Going Ex-Dividend
10 Oversold Canadian Stocks
10 Canadian Stocks Where Yields Got More Juicy
10 Must-Know High-Yield Canadian Real Estate Stocks
10 Top DividendRank'ed Canadian Financials
10 Must-Know High-Yield Canadian Energy Stocks
10 Canadian Stocks Crossing Below Book Value
10 Canadian Stocks Crossing Above Their 200 Day Moving Avg
10 Canadian Stocks Crossing Below Their 200 Day Moving Avg
Stock market game


PARTNER NEWS:

Fri, Aug 26, 8:27 AM, Zacks
Biotech ETFs in Focus After Mylan's EpiPen Controversy
Mylan offers discounts to the purchase of EpiPen to cool down criticism over its steep price. How will biotech ETFs take this move?

Wed, Aug 24, 3:29 PM, Zacks
Did Hillary Clinton's Tweet Cause the Sell-Off in Mylan (MYL) Stock?
Shares of pharmaceutical giant Mylan Inc. (MYL) fell over 5.5% in afternoon trading Wednesday after Hillary Clinton tweeted about its price hikes of the EpiPen medication.

ETF Stock Holdings | IBB | Page 1 | ETF Channel | www.ETFChannel.com | Copyright © 2009 - 2016, All Rights Reserved

Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; ETF data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.